GPT and Decreased liver function: With respect to laboratory results, differences in liver and renal function between the two groups were not statistically significant (Table 2), although one patient in the leflunomide group had liver dysfunction on day two and therefore discontinued treatment (ALT 120 U/L, AST 97 U/L).